At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for Cancer

by Garassino, Marina Chiara, Ribas, Antoni
Published in Cancer Immunol Res (2021)

Evaluation of safety and efficacy of tivantinib in the treatment of inoperable or recurrent non-small-cell lung cancer

by Broggini, Massimo, Garassino, Marina Chiara, Damia, Giovanna
Published 2013

Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake?

by Lo Russo, Giuseppe, Proto, Claudia, Garassino, Marina Chiara
Published in Transl Lung Cancer Res (2016)

New findings on thymic epithelial tumors: Something is changing

by Berardi, Rossana, Morgese, Francesca, Garassino, Marina Chiara, Cascinu, Stefano
Published in World J Clin Oncol (2015)

2020s Heroes Are Not Fearless: The Impact of the COVID-19 Pandemic on Wellbeing and Emotions of Italian Health Care Workers During Italy Phase 1

by Marton, Giulia, Vergani, Laura, Mazzocco, Ketti, Garassino, Marina Chiara, Pravettoni, Gabriella
Published in Front Psychol (2020)

Myeloid cell heterogeneity in lung cancer: implication for immunotherapy

by Sangaletti, Sabina, Ferrara, Roberto, Tripodo, Claudio, Garassino, Marina Chiara, Colombo, Mario Paolo
Published in Cancer Immunol Immunother (2021)

Regulation of PD-L1 Expression by NF-κB in Cancer

by Antonangeli, Fabrizio, Natalini, Ambra, Garassino, Marina Chiara, Sica, Antonio, Santoni, Angela, Di Rosa, Francesca
Published in Front Immunol (2020)

Severity of COVID-19 in patients with lung cancer: evidence and challenges

by Passaro, Antonio, Bestvina, Christine, Velez Velez, Maria, Garassino, Marina Chiara, Garon, Edward, Peters, Solange
Published in J Immunother Cancer (2021)

Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations

by Ferrara, Roberto, Signorelli, Diego, Proto, Claudia, Prelaj, Arsela, Garassino, Marina Chiara, Lo Russo, Giuseppe
Published in Transl Lung Cancer Res (2021)

MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review

by Lo Russo, Giuseppe, Tessari, Anna, Capece, Marina, Galli, Giulia, de Braud, Filippo, Garassino, Marina Chiara, Palmieri, Dario
Published in Front Oncol (2018)

Beyond LKB1 Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment

by Borzi, Cristina, Galli, Giulia, Ganzinelli, Monica, Signorelli, Diego, Vernieri, Claudio, Garassino, Marina Chiara, Sozzi, Gabriella, Moro, Massimo
Published in Pharmaceuticals (Basel) (2020)

Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don’t) know

by Camelliti, Simone, Le Noci, Valentino, Bianchi, Francesca, Moscheni, Claudia, Arnaboldi, Francesca, Gagliano, Nicoletta, Balsari, Andrea, Garassino, Marina Chiara, Tagliabue, Elda, Sfondrini, Lucia, Sommariva, Michele
Published in J Exp Clin Cancer Res (2020)

Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells

by Caiola, Elisa, Salles, Daniela, Frapolli, Roberta, Lupi, Monica, Rotella, Giuseppe, Ronchi, Anna, Garassino, Marina Chiara, Mattschas, Nikola, Colavecchio, Stefano, Broggini, Massimo, Wiesmüller, Lisa, Marabese, Mirko
Published in Oncotarget (2015)

Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 cases

by Lo Russo, Giuseppe, Imbimbo, Martina, Corrao, Giulia, Proto, Claudia, Signorelli, Diego, Vitali, Milena, Ganzinelli, Monica, Botta, Laura, Zilembo, Nicoletta, de Braud, Filippo, Garassino, Marina Chiara
Published in Oncotarget (2017)

Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab

by Banna, Giuseppe Luigi, Signorelli, Diego, Metro, Giulio, Galetta, Domenico, De Toma, Alessandro, Cantale, Ornella, Banini, Marco, Friedlaender, Alex, Pizzutillo, Pamela, Garassino, Marina Chiara, Addeo, Alfredo
Published in Transl Lung Cancer Res (2020)

Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient da...

by Garassino, Marina Chiara, Kawaguchi, Tomoya, Gregorc, Vanesa, Rulli, Eliana, Ando, Masahiko, Marsoni, Silvia, Isa, Shun-ichi, Novello, Silvia, Farina, Gabriella, Barni, Sandro, Torri, Valter, Cinquini, Michela
Published in ESMO Open (2018)

Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future

by Proto, Claudia, Imbimbo, Martina, Gallucci, Rosaria, Brissa, Angela, Signorelli, Diego, Vitali, Milena, Macerelli, Marianna, Corrao, Giulia, Ganzinelli, Monica, Greco, Francesca Gabriella, Garassino, Marina Chiara, Lo Russo, Giuseppe
Published in Transl Lung Cancer Res (2016)

Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey

by Banerjee, Susana, Dafni, Urania, Allen, Tamara, Arnold, Dirk, Curigliano, Giuseppe, Garralda, Elena, Garassino, Marina Chiara, Haanen, John, Hofstädter-Thalmann, Eva, Robert, Caroline, Sessa, Cristiana, Tsourti, Zoi, Zygoura, Panagiota, Peters, Solange
Published in ESMO Open (2018)

Report on the status of women occupying leadership roles in oncology

by Hofstädter-Thalmann, Eva, Dafni, Urania, Allen, Tamara, Arnold, Dirk, Banerjee, Susana, Curigliano, Giuseppe, Garralda, Elena, Garassino, Marina Chiara, Haanen, John, Robert, Caroline, Sessa, Cristiana, Tsourti, Zoi, Zygoura, Panagiota, Peters, Solange
Published in ESMO Open (2018)

Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients

by Nichetti, Federico, Ligorio, Francesca, Zattarin, Emma, Signorelli, Diego, Prelaj, Arsela, Proto, Claudia, Galli, Giulia, Marra, Antonio, Apollonio, Giulia, Porcu, Luca, de Braud, Filippo, Lo Russo, Giuseppe, Ferrara, Roberto, Garassino, Marina Chiara
Published in Cancers (Basel) (2019)